Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Teixeira, Geneviève
DOB: 10-MAY-1977 (Age: 48)
Gender: female
Address:
863, boulevard de Bigot
03130 Léger-sur-Robin (France)
ID: 5170-765314-6 (ECI)
Report
Date: 22-SEP-2020
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Centre Médico-psychologique
42300 Roanne (France)
Specimen
Collected: 22-SEP-2020

Chemistry

Test 22-SEP-2020 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.0 H 4.0 - 5.6 %
Glucose [Mass/volume] in Blood 73.6 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 8.3 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 10.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 141.2 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 108.1 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 28.0 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 195.8 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 117.5 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 114.4 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 57.9 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c, indicating impaired glucose metabolism or possible prediabetes, and elevated LDL cholesterol, which increases cardiovascular risk. Other parameters, including renal function, electrolytes, and lipid profile, are within normal limits. Recommend follow-up for glycemic control and lipid management.